Breaking News on Contract Research, Manufacturing & Clinical Trials

Go

All feeds

News headlines > Preclinical Research

CBI plants presence in Japan

19-Jun-2008 - Commonwealth Biotechnologies (CBI) has planted its first roots in Japan, as the world's number two pharmaceutical market continues to attract foreign firms.

AstraZeneca taps WuXi for more screening services

12-Jun-2008 - AstraZeneca's travels down the outsourcing route have continued this week, with an extension to its contract with China's WuXi Pharmatech.

Akela Pharma to sue LAB Research over tox studies

12-Jun-2008 - Akela Pharma has notified LAB Research of its intention to initiate legal proceedings to recover the cost of preclinical studies it ran in Hungary that were rejected by the US regulatory authorities.

CROs must play greater development role

09-Jun-2008 - In the future, drug firms will expect Asian contract research organizations (CRO) to offer improved discovery, development and management capabilities, according to Commonwealth Biotechnologies (CBI) CEO Paul D'Sylva.

Singapore pushing to dominate translational research in Asia

05-Jun-2008 - Singapore's Economic Development Board has been taking strides over the past year to further its biomedical sciences industry and vie for global attention amidst the other Asia Pacific players, particularly in the field of translational research.

Canada to tighten up biosecurity laws with new bill

30-May-2008 - Canada has bought its laboratory legislation in line with other international standards as the country proposes new legislation designed to tighten safety and access to human pathogens and toxins.

GVK BIO secures Wyeth deal

29-May-2008 - India's GVK BIO has secured a new research agreement with drug giant Wyeth Pharmaceuticals, as more and more pharma firms are relying on outside partners for drug discovery innovations.

Strong growth fuels ambition to expand at Neuland

29-May-2008 - India's Neuland Laboratories is expanding its service offering with a shift into contract research and clinical testing via a joint venture with Cato Research of the US.

Galapagos confident of profit turnaround in services unit

27-May-2008 - In a business update discussing its first quarter results of 2008, Galapagos said it is on track to pull its services division back out of the red during the year.

Quotient consolidates its growing business

22-May-2008 - Quotient BioResearch has consolidated its three latest drug development acquisitions under a united front and the hungry firm is now on the hunt for further purchases.

PPI partners with UK services firm

20-May-2008 - Pharmaceutics International (PII) has cemented a new partnership with a UK firm that will see it gain bring new preclinical and clinical services to the North American market.

Preclinical services news in brief

12-May-2008 - In this week's review of activity within the preclinical research services arena, news has emerged involving Galapagos, Evotec and Caliper Life Sciences.

Charles River shows Q1 profit growth

09-May-2008 - Charles River Laboratories has again witnessed a profit growth, as it reports its first quarter results for 2008.

Bioprocessing holds back Millipore in Q1

07-May-2008 - Continued weakness in the market for products used in the manufacture of biologic drugs was the main reason why Millipore experienced a 'challenging' quarter, according to CEO Martin Madaus.

China's preclinical services scene evolving outwards

07-May-2008 - China's preclinical services providers are beginning to carve a niche for themselves on the global stage, buoyed by the growth of the domestic market.

MPI Research initiates $330m growth plan

01-May-2008 - US preclinical services firm MPI Research has revealed its intentions to undertake a $330m that will result in the creation of 3,300 new jobs.

Preclinical services news in brief

29-Apr-2008 - In this week's review of activity within the preclinical research services arena, news has emerged involving MIR Preclinical Services, Commonwealth Biotechnologies and Innogenetics.

Certification supports BioDuro's global ambitions

29-Apr-2008 - US-based BioDuro and The National Center for Safety Evaluation of Drugs (NCSED) in Beijing have received full accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC).

Pharmaceutical outsourcing: people on the move

21-Apr-2008 - Galapagos, BioReliance, Parexel, MDS Pharma Services and PharmEng have all had people on the move in the world of pharmaceutical outsourcing.

Preclinical services news in brief

17-Apr-2008 - In this week's round-up of activity within the preclinical research services arena, news has emerged involving Exelgen, Epistem, Sareum Holdings and WuXi PharmaTech.

Pharmaceutical outsourcing: people on the move

10-Apr-2008 - PPD, INC Research, Parexel, Cato Research, Pacific Biomarkers and Discovery Laboratories have all had people on the move in the world of pharmaceutical outsourcing.

Preclinical services news in brief

07-Apr-2008 - In this week's review of activity within the preclinical research services arena, news has emerged involving GenOway, Evotec and Cenix.

Expression Analysis buys novel DNA sequencing technology

25-Mar-2008 - Genomic services firm Expression Analysis has purchased the first-ever commercially-available technology to allow the sequencing of a single molecule of DNA, without amplification.

Affymetrix to outsource jobs to Singapore

20-Mar-2008 - Microarray expert Affymetrix has started outsourcing some of its jobs in the US to Singapore.

Applied Bio sequences a human genome for $60,000

18-Mar-2008 - Applied Biosystems has sequenced a human genome for just $60,000 in a project that significantly undercuts the $100,000 milestone achieved by the industry and setting the scene for a price war between DNA sequencing tool specialists.